Association of postprandial and fasting plasma glucose with HbA1c across the spectrum of glycaemic impairment in type 2 diabetes

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 71, Iss. 12, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of HbA 1c in Screening for Cuban-Americans with Undiagnosed Type 2 Diabetes

By Huffman Fatma  

Journal of Immigrant and Minority Health, Vol. 13, Iss. 3, 2011-06 ,pp. : 541-545

Springer Publishing Company

Access to resources Recommend Favorite

GLP-1 receptor agonists and HBA_1c target of <7%% in type 2 diabetes: meta-analysis of randomized controlled trials

By Esposito K.   Mosca C.   Brancario C.   Chiodini P.   Ceriello A.   Giugliano D.  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1519-1528

Informa Healthcare

Access to resources Recommend Favorite

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 409-418

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Changes in HbA_1c, Lipids and Blood Pressure on Long-term Outcomes in Type 2 Diabetes Patients: An Analysis Using the CORE Diabetes Model

By Palmer Andrew J.   Roze Stéphane   Valentine William J.   Minshall Michael E.   Hayes Clarice   Oglesby Alan   Spinas Giatgen A.  

Current Medical Research and Opinion, Vol. 20, Iss. 1, 2004-08 ,pp. : 53-58

Informa Healthcare

Access to resources Recommend Favorite